Literature DB >> 34229088

Diffusion MRI detects basal forebrain cholinergic abnormalities in the 3xTg-AD mouse model of Alzheimer's disease.

Maria Fatima Falangola1, Xingju Nie2, Ralph Ward3, Siddhartha Dhiman4, Joshua Voltin4, Paul J Nietert3, Jens H Jensen5.   

Abstract

Degeneration of the basal forebrain (BF) is detected early in the course of Alzheimer's disease (AD). Reduction in the number of BF cholinergic (ChAT) neurons associated with age-related hippocampal cholinergic neuritic dystrophy is described in the 3xTg-AD mouse model; however, no prior diffusion MRI (dMRI) study has explored the presence of BF alterations in this model. Here we investigated the ability of diffusion MRI (dMRI) to detect abnormalities in BF microstructure for the 3xTg-AD mouse model, along with related pathology in the hippocampus (HP) and white matter (WM) tracks comprising the septo-hippocampal pathway. 3xTg-AD and normal control (NC) mice were imaged in vivo using the specific dMRI technique known as diffusional kurtosis imaging (DKI) at 2, 8, and 15 months of age, and 8 dMRI parameters were measured at each time point. Our results revealed significant lower dMRI values in the BF of 2 months-old 3xTg-AD mice compared with NC mice, most likely related to the increased number of ChAT neurons seen in this AD mouse model at this age. They also showed significant age-related dMRI changes in the BF of both groups between 2 and 8 months of age, mainly a decrease in fractional anisotropy and axial diffusivity, and an increase in radial kurtosis. These dMRI changes in the BF may be reflecting the complex aging and pathological microstructural changes described in this region. Group differences and age-related changes were also observed in the HP, fimbria (Fi) and fornix (Fx). In the HP, diffusivity values were significantly higher in the 2 months-old 3xTg-AD mice, and the HP of NC mice showed a significant increase in axial kurtosis after 8 months, reflecting a normal pattern of increased fiber density complexity, which was not seen in the 3xTg-AD mice. In the Fi, mean and radial diffusivity values were significantly higher, and fractional anisotropy, radial kurtosis and kurtosis fractional anisotropy were significantly lower in the 2 months-old 3xTg-AD mice. The age trajectories for both NC and TG mice in the Fi and Fx were similar between 2 and 8 months, but after 8 months there was a significant decrease in diffusivity metrics associated with an increase in kurtosis metrics in the 3xTg-AD mice. These later HP, Fi and Fx dMRI changes probably reflect the growing number of dystrophic neurites and AD pathology progression in the HP, accompanied by WM disruption in the septo-hippocampal pathway. Our results demonstrate that dMRI can detect early cytoarchitectural abnormalities in the BF, as well as related aging and neurodegenerative changes in the HP, Fi and Fx of the 3xTg-AD mice. Since DKI is widely available on clinical scanners, these results also support the potential of the considered dMRI parameters as in vivo biomarkers for AD disease progression.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3xTg-AD mouse; Alzheimer's disease; Cholinergic basal forebrain; Diffusion MRI; Diffusional kurtosis imaging; White matter

Mesh:

Substances:

Year:  2021        PMID: 34229088      PMCID: PMC8449815          DOI: 10.1016/j.mri.2021.06.022

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  63 in total

1.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

Review 2.  The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.

Authors:  Julie A Dumas; Paul A Newhouse
Journal:  Pharmacol Biochem Behav       Date:  2011-03-05       Impact factor: 3.533

3.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

4.  Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.

Authors:  Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

5.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

Review 6.  The aging brain.

Authors:  H Brody
Journal:  Acta Neurol Scand Suppl       Date:  1992

Review 7.  Septo-hippocampo-septal loop and memory formation.

Authors:  Fatemeh Khakpai; Mohammad Nasehi; Ali Haeri-Rohani; Akram Eidi; Mohammad Reza Zarrindast
Journal:  Basic Clin Neurosci       Date:  2013

8.  Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.

Authors:  Georg M Kerbler; Jürgen Fripp; Christopher C Rowe; Victor L Villemagne; Olivier Salvado; Stephen Rose; Elizabeth J Coulson
Journal:  Neuroimage Clin       Date:  2014-11-27       Impact factor: 4.881

Review 9.  Septo-hippocampal interaction.

Authors:  Christina Müller; Stefan Remy
Journal:  Cell Tissue Res       Date:  2017-12-18       Impact factor: 5.249

View more
  2 in total

Review 1.  Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis.

Authors:  Ruiqing Ni
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 2.  Neuroimaging of Mouse Models of Alzheimer's Disease.

Authors:  Amandine Jullienne; Michelle V Trinh; Andre Obenaus
Journal:  Biomedicines       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.